Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Therapy-Associated Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Not Yet RecruitingNCT07782359
What this trial is testing

Impact of Using a GLP1 on Treatment Related Side Effects of Lung Cancer Patients Receiving Lorlatinib

Who this might be right for
Lung Cancer
University of Chicago 30
Early research (Phase 1)Enrolling By InvitationNCT05635591
What this trial is testing

KSD-101 Therapy for EBV-associated Haematologic Neoplasms: an Exploratory Clinical Trial

Who this might be right for
EBV-associated Haematologic Neoplasms
Tongji Hospital 9
Large-scale testing (Phase 3)UnknownNCT00020865
What this trial is testing

Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia

Who this might be right for
Fever, Sweats, and Hot FlashesInfectionLeukemia+3 more
Jonsson Comprehensive Cancer Center
Very early researchNot Yet RecruitingNCT07066436
What this trial is testing

ImmunoMRI for Assessment of Tumor-associated Macrophages

Who this might be right for
DLBCL - Diffuse Large B Cell Lymphoma
Medical University of Vienna 60
Large-scale testing (Phase 3)Ended earlyNCT00637806
What this trial is testing

Treatment of Cancer-associated Anorexia Using Megestrol Acetate Concentrated Suspension

Who this might be right for
AnorexiaCachexiaWeight Loss
Par Pharmaceutical, Inc. 4
Early research (Phase 1)Ended earlyNCT04672980
What this trial is testing

RTX-321 Monotherapy in Patients With HPV 16+ Tumors

Who this might be right for
Cervical CancerHead and Neck CancerAnal Cancer
Rubius Therapeutics 9
Not applicableLooking for participantsNCT00200486
What this trial is testing

Molecular and Genomic Profiling of Head and Neck Tumors

Who this might be right for
Head and Neck Neoplasms
Montefiore Medical Center 1,000
Not applicableEnded earlyNCT00005786
What this trial is testing

Arsenic Trioxide in Treating Patients With Relapsed or Refractory Lymphoma or Leukemia

Who this might be right for
Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaProlymphocytic Leukemia+8 more
National Cancer Institute (NCI) 25
Not applicableLooking for participantsNCT07173166
What this trial is testing

Non-Pharmacological Interventions for Neurotoxicity in Hematologic Patients Receiving CAR-T Therapy

Who this might be right for
Hematologic Cancer
Instituto de Investigacion Sanitaria INCLIVA 338
Not applicableStudy completedNCT00376922
What this trial is testing

Music in Reducing Anxiety and Pain in Adult Patients Undergoing Bone Marrow Biopsy for Hematologic Cancers or Other Diseases

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+7 more
Wake Forest University Health Sciences 65
Not applicableUnknownNCT02987127
What this trial is testing

Prospective Study of Frontline H Pylori Eradication in the Treatment of Early-stage Extragastric MALT Lymphoma

Who this might be right for
Mucosa-Associated Lymphoid Tissue Lymphoma
National Taiwan University Hospital 21
Testing effectiveness (Phase 2)Study completedNCT00082888
What this trial is testing

Tipifarnib in Treating Patients With Relapsed or Refractory Lymphoma

Who this might be right for
Anaplastic Large Cell LymphomaExtranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid TissueMature T-Cell and NK-Cell Non-Hodgkin Lymphoma+10 more
National Cancer Institute (NCI) 93
Very early researchNot Yet RecruitingNCT07563023
What this trial is testing

Exploratory Study on the Treatment of EB Virus Positive HIV Associated Lymphoma With EBV mRNA Vaccine

Who this might be right for
HIV Associated Lymphoma
West China Hospital 6
Early research (Phase 1)Study completedNCT00392691
What this trial is testing

Melphalan, Yttrium Y 90 Ibritumomab Tiuxetan, and Rituximab Followed by Autologous Stem Cell Transplant in Treating Older Patients With Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment

Who this might be right for
Lymphoma
Swiss Cancer Institute 20
Not applicableLooking for participantsNCT07160270
What this trial is testing

This Study Aims to Clarify the Prevalence and Characteristics of Neuropathy, Along With Associated Paraclinical Findings in Patients With Waldenström's Macroglobulinemia (WM) in a Cohort of WM Patients to Optimize the Diagnostic Process

Who this might be right for
Waldenstrom MacroglobulinaemiaPeripheral Neuropathies
Rigshospitalet, Denmark 90
Very early researchNot Yet RecruitingNCT06370026
What this trial is testing

KSD-101 Therapy for Standard Treatment Failed EBV-associated NPC: an Exploratory Clinical Trial

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 12
Not applicableStudy completedNCT01053494
What this trial is testing

Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Undifferentiated LeukemiaAngioimmunoblastic T-cell Lymphoma+84 more
Wake Forest University Health Sciences 80
Not applicableStudy completedNCT00201422
What this trial is testing

Eradication of Helicobacter Pylori in the Management of Stage IE & IIE-1 Primary Low-grade B Cell Lymphoma of MALToma

Who this might be right for
MALT Lymphoma
National Health Research Institutes, Taiwan 70
Testing effectiveness (Phase 2)UnknownNCT01697891
What this trial is testing

A Pilot Study of ALTENS in Improving Dysphagia Induced by IMRT for Head and Neck Cancers

Who this might be right for
Head and Neck CancerDysphagia
McMaster University 35
Post-approval studies (Phase 4)Study completedNCT00230217
What this trial is testing

Study of Rasburicase as Treatment or Prevention of Hyperuricemia Associated With Tumor Lysis Syndrome in Patients With Relapsed or Refractory Lymphoma, Leukemia, or Solid Tumor Malignancy

Who this might be right for
TumorsHyperuricemiaTumor Lysis Syndrome
Sanofi 94
Next Page